Black Rock Inc. Evotec Se Put Options Transaction History
Black Rock Inc.
- $4.23 Trillion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding EVO
# of Institutions
21Shares Held
347KCall Options Held
0Put Options Held
0-
Morgan Stanley New York, NY87.6KShares$420,5080.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny82.8KShares$397,5120.0% of portfolio
-
Dcf Advisers, LLC Greenwich, CT47.8KShares$229,4250.19% of portfolio
-
Optiver Holding B.V. Amsterdam, P741.5KShares$199,2330.01% of portfolio
-
Cetera Investment Advisers Schaumburg, IL24.5KShares$117,8060.0% of portfolio
About Evotec SE
- Ticker EVO
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 353,904,992
- Market Cap $1.7B
- Description
- Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare di...